Nancy Pérez-Rodas
Nancy Pérez-Rodas has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro Frino-García
Department of Pulmonology, Hospital Clínic de Barcelona, Barcelona, Spain
1 shared publication - Elvis Matheus Ramirez
Hospital General Monte Sinaí, Guayaquil, Ecuador
1 shared publication - Fernanda Hernandez-Gonzalez
Pulmonology Department, Hospital Clinic, 08402 Barcelona, Spain
1 shared publication - Jacobo Sellares
Hospital Clinic, Barcelona, Spain
1 shared publication - María Belén Noboa-Sevilla
Hospital Metropolitano de Quito-Ecuador
1 shared publication - Miguel Alonso-Villares
Severo Ochoa Hospital, Leganés, 28911 Madrid, Spain
1 shared publication
Latest Publications
- Open Access
- 1 September 2025
- Published by MDPI AG in Journal of Respiration
- Vol. 5 (3) , 14
Evolving Concepts in Progressive Pulmonary Fibrosis: A Clinical Update
Progressive pulmonary fibrosis (PPF) is a clinical syndrome associated with worsening quality of life and increased mortality among patients with various interstitial lung diseases. This review aims to update the concepts and criteria that adequately define PPF, aiming to facilitate earlier recognition and optimize clinical management. Fibrosing interstitial lung disease (ILD-f) can progress over time despite optimal management of the underlying conditions. Current criteria for defining PPF include worsening respiratory symptoms, decline in pulmonary function tests (particularly forced vital capacity and diffusing capacity), and radiographic progression over a 1-year follow-up period. However, implementation of these criteria in clinical practice poses challenges. This review discusses the limitations of current evaluation methods and proposes future directions, including the need for validated symptom assessment tools, standardization of pulmonary function testing, and improvements in quantitative radiological evaluation methods.
- 1 September 2025
- Published by MDPI AG in Journal of Respiration
- Vol. 5 (3) , 14
Open AccessEvolving Concepts in Progressive Pulmonary Fibrosis: A Clinical Update
Progressive pulmonary fibrosis (PPF) is a clinical syndrome associated with worsening quality of life and increased mortality among patients with various interstitial lung diseases. This review aims to update the concepts and criteria that adequately define PPF, aiming to facilitate earlier recognition and optimize clinical management. Fibrosing interstitial lung disease (ILD-f) can progress over time despite optimal management of the underlying conditions. Current criteria for defining PPF include worsening respiratory symptoms, decline in pulmonary function tests (particularly forced vital capacity and diffusing capacity), and radiographic progression over a 1-year follow-up period. However, implementation of these criteria in clinical practice poses challenges. This review discusses the limitations of current evaluation methods and proposes future directions, including the need for validated symptom assessment tools, standardization of pulmonary function testing, and improvements in quantitative radiological evaluation methods.